Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05794204
PHASE2

RMP-A03 Ocular Suspension in Patients With Pterygium

Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd.

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Official title: A Phase 1/2a Study Evaluating the Safety and Efficacy of RMP-A03 Ocular Suspension in Healthy Volunteers and Patients With Pterygium

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

77

Start Date

2023-06-09

Completion Date

2024-01-12

Last Updated

2026-06-05

Healthy Volunteers

No

Conditions

Interventions

DRUG

RMP-A03 - Dose 1

Patients will randomized to low dose of RMP-A03

DRUG

RMP-A03 - Dose 2

Patients will be randomized to high dose of RMP-A03

DRUG

RMP-A03 Placebo

Patients will be randomized to RMP-A03 Placebo

Locations (6)

Global Research Management

Glendale, California, United States

United Medical Research Institute

Inglewood, California, United States

Eye Research Foundation Inc

Newport Beach, California, United States

Oceane7 Medical & Research Center Inc.

Miami, Florida, United States

Toyos Clinic

Nashville, Tennessee, United States

Keystone Research

Austin, Texas, United States